Investment Process

During the investment selection process BB Biotech relies on the well established experience of its Board of Directors and the fundamental analyses by the experienced management team of Bellevue Asset Management Group, with access to a network of physicians and specialists for the sectors in question.

In doing so, a detailed financial model is created for each holding, which guarantees a compelling illustration of the potential for doubling asset values in a period of four years. This potential is based on the power for innovation, new products for serious or significant illnesses and outstanding management.

Before making a positive investment decision, intensive contact is established with the target company’s management, since we are convinced that a superior performance can only be achieved with well managed companies.

After being incorporated into BB Biotech’s portfolio, intense personal contact is maintained with members of the management of the relevant holdings. This closely knit monitoring of the portfolio companies enables BB Biotech to utilize all strategic options on a timely basis, including the early disposal of an equity interest should the fundamental situation significantly deteriorate.

During the investment selection process BB Biotech relies on the well established experience of its Board of Directors and the fundamental analyses by the experienced management team of Bellevue Asset Management Group, with access to a network of physicians and specialists for the sectors in question.

In doing so, a detailed financial model is created for each holding. The growth potential is based on the power for innovation, new products for serious or significant illnesses and outstanding management.

Before making a positive investment decision, intensive contact is established with the target company’s management, since we are convinced that a superior performance can only be achieved with well managed companies.

After being incorporated into BB Biotech’s portfolio, intense personal contact is maintained with members of the management of the relevant holdings. This closely knit monitoring of the portfolio companies enables BB Biotech to utilize all strategic options on a timely basis, including the early disposal of an equity interest should the fundamental situation significantly deteriorate.